## Abstract ## BACKGROUND Gemcitabineβassociated thrombotic microangiopathy (TMA) is believed to be very rare, with an estimated incidence rate of 0.015%. Indications for gemcitabine are expanding, and comprehensive characterization of this complication is therefore important. ## METHODS The aut
β¦ LIBER β¦
Doxycycline, gastrointestinal bleeding, and thrombotic microangiopathy
β Scribed by Hassane Izzedine; Vincent Launay-Vacher; Lucille Mercadal; Jean-Paul Vernant; Gilbert Deray
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 55 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Gemcitabine-associated thrombotic microa
β
Benjamin D. Humphreys; Jeff P. Sharman; Joel M. Henderson; Jeffrey W. Clark; Pet
π
Article
π
2004
π
John Wiley and Sons
π
English
β 158 KB
Thrombotic microangiopathy and intraveno
β
Toru Watanabe
π
Article
π
2007
π
Springer
π
English
β 51 KB
Pathogenesis and prognosis of thrombotic
β
Masaomi Nangaku; Hiroshi Nishi; Toshiro Fujita
π
Article
π
2007
π
Springer
π
English
β 208 KB
Subacute (acute, persistent) thrombotic
β
Edwin G. Taft; Bala B. Carver
π
Article
π
1992
π
John Wiley and Sons
π
English
β 208 KB
## Abstract Six patients with prolonged acute courses of thrombotic microangiopathy are reviewed. These patients had in common courses of acute disease requiring plasma support for more than 3 months, with subsequent complete remission. Plasma support requirements may be prodigious, and the acute c
Thrombotic microangiopathies and intensi
β
FranΓ§ois Vincent; Christophe Clecβh; Philippe Karoubi
π
Article
π
2005
π
Springer
π
English
β 98 KB
Rapidly progressive lupus nephritis and
β
Chems Gharbi; Edward Bourry; Philippe Rouvier; Sabria Hacini; Ahmed Letaief; Ala
π
Article
π
2010
π
Springer
π
English
β 433 KB